|
Market Cap (5-Jun) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
PAA released this announcement to the ASX on 21 October 2020, 8:16. The announcement is not marked as price sensitive, and is 13 page(s) in length and 280.13kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.031% short sold according to ASIC data. It was ranked the 458th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Motor Neurone Disease Phase 1/2 Clinical Trial Update | 27 June 2023, 8:17 |
| Commencement of Cohort 3 in Phase 1/2 MND Trial | 9 June 2023, 9:54 |
| PharmAust MND Trial Interim Analysis PK Outcomes | 7 June 2023, 9:31 |
| Appendix 3G | 21 October 2020, 8:16 |
| There has been no announcements made to the ASX since this one. |
You must be logged in to post a reply.
PharmAust 